.png)
Partnering with local clinics allows Curebase to streamline workflows and eliminate unnecessary tasks while establishing optimized recruitment practices.
Written by Dr. Charles Baum, Curebase Principal Investigator and former VP of US and EU Medical Affairs at Takeda Pharmaceuticals
Jane Myles, Curebase's VP of Clinical Trial Innovation, shares perspectives on the current state of adoption of decentralized clinical trials.
.png)
This comprehensive overview illustrates the intersection between prescription digital therapeutics, digital health tools, and decentralized clinical trials in a remote care setting.
Curebase's Sr. Director of Program Development in Europe, Katri Langel, breaks down five major EU life sciences regulations and policy changes impacting the future of clinical trials in Europe.
At Curebase we are rapidly expanding and preparing for the wave of decentralization in clinical trials that we intend to lead. To that end we have recently hired a Director of Clinical Operations, Adam Samson...
At Curebase we are rapidly expanding and preparing for the wave of decentralization in clinical trials that we intend to lead. To that end we have recently hired a Director of Clinical Operations, Adam Samson...
Get our most recent blogs, whitepapers, webinars and case studies delivered straight to your inbox.
.svg)
%201.svg){kind=logo}
